Efficacy and hazards of 425 nm oral cavity light dosing to inactivate SARS-CoV-2

OBJECTIVE: Using a battery of preclinical tests to support development of a light-based treatment for COVID-19, establish a range of 425 nm light doses that are non-hazardous to the tissues of the oral cavity and assess whether a 425 nm light dose in this non-hazardous range can inactivate SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockslager, Max A., Kocher, Jacob F., Arwood, Leslee, Stasko, Nathan, McDonald, Rebecca A., Tapsak, Mark A., Emerson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212724/
https://www.ncbi.nlm.nih.gov/pubmed/35724941
http://dx.doi.org/10.1016/j.jdent.2022.104203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212724/
https://www.ncbi.nlm.nih.gov/pubmed/35724941
http://dx.doi.org/10.1016/j.jdent.2022.104203

Ejemplares similares